Heli Harvala
Papers
1
Total Citations
17
H-Index
1
About
Dr. Heli Harvala is a leading virologist whose research centers on transfusion-transmitted infections, emerging viruses, and the immunological response to SARS-CoV-2. Her most impactful work has focused on evaluating the efficacy and safety of convalescent plasma therapy during the COVID-19 pandemic, providing critical insights into antibody titers and donor potency. Her 2020 commentary on SARS-CoV-2 antibody assessment, with 17 citations, helped shape guidelines for convalescent plasma donation, addressing urgent global needs for therapeutic options. Beyond this, Dr. Harvala has made significant contributions to understanding blood-borne viruses, including hepatitis E and emerging arboviruses, improving donor screening protocols and public health preparedness. Her research has been instrumental in bridging virology and transfusion medicine, influencing both clinical practice and pandemic response strategies. With a career marked by high-impact publications and collaborations, Dr. Harvala continues to advance knowledge on viral transmission and immunity, making her a respected voice in infectious disease research and a vital resource for students and clinicians navigating the complexities of emerging pathogens.
Research Focus
Key Achievements
Top Papers
- 1